PharmD · Oregon

Collaborative Drug Therapy Management for Pharmacists in Oregon

No. Pharmacists here manage drug therapy on their own authority. Oregon calls it a CDTM Protocol.

Practice authorityIndependent practice
Written agreementNo agreement required
What Oregon calls itCDTM Protocol
Agreement familyCollaborative Practice
Research date2026-09-03 · clauses 2026-09-03

Oregon grants pharmacists direct statutory prescriptive authority for a Board-defined formulary (ORS 689.645: diabetic supplies, emergency insulin, albuterol, epinephrine, smoking-cessation aids and similar) and for hormonal contraceptives (ORS 689.689), grounded in statute and, for the formulary, a prior diagnosis by another prescriber, not a physician collaboration or CDTM agreement. Whether a separate agreement-based collaborative drug therapy management pathway also exists is not covered here.

What the collaboration must look like

The rules the physician relationship has to follow. Each fact comes from the statute or board rule listed under sources.

Proximity

Not codified

Supervision ratio

Not codified — no cap on file

Chart review

Not codified

Meeting cadence

Not codified

Prescriptive authority

No agreement needed to prescribe · no controlled-substance authority

Neither statutory authority researched here extends to DEA-scheduled controlled substances; whether any separate Oregon pharmacist authority reaches controlled substances (e.g. naloxone, which is not scheduled) was not exhaustively checked.

Written agreement

Not required

Unconditional for the statutory formulary and contraceptive authority covered here; no physician agreement is required for either. Whether a distinct agreement-based CDTM pathway also exists in Oregon, as in many other states, is not covered here.

Practice ownership (corporate practice of medicine)

Non-licensee ownership permitted — Drug outlets register with the State Board of Pharmacy (ORS 689.305) and may be corporate entities; the statute contemplates employees of a registered corporation, implying corporate ownership is permitted under the usual pharmacist-in-charge model. Confirm the specific pharmacist-in-charge provision

Materially more permissive than the physician/PA/NP/APRN entity-ownership rules above.

Sources for the supervision rules (4)
The document: CDTM Protocol
What an Oregon CDTM Protocol covers when a practice chooses to use one: read the CDTM Protocol page on practiceagreement.com.

What a collaborating physician costs here

Typical monthly cost in Oregon

$500$600

Estimate for one Pharmacist. Standard-tier state.

About Oregon's rules

Oregon has no physician-supervision requirement for NP/CNS/CRNA and replaced PA 'supervision' with a non-supervisory 'collaboration agreement' (ORS 677.495-677.525, recodified by H.B. 4010, eff. June 6, 2024). CNM and PMHNP are population foci under the single NP license (OAR 851-050-0005), not separate license categories. CRNA/CNS entity co-ownership with physicians is unconfirmed — ORS 58.376 names only physicians, PAs, and NPs.

Other clinicians in Oregon: see the state overview.

Confirming your browser